Nil Patel, DPM
Foot & Ankle Surgery · Saint Louis, MONPI 1942838115
Payments from drug & device makers
Across 90 payments — averaging $81.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$2K
- Stryker$2K
- Organogenesis Inc.$901
- Elite Orthopedics, LLC$706
- Arthrex$475
- Smith+Nephew$359
- plus $2K from 16 others
What the payments were for
- Travel & lodging$1,38919%
- Food & beverage$4,54362%
- Other$1,42319%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 10 | $1,784 |
| Stryker | 12 | $1,605 |
| Organogenesis Inc. | 18 | $901 |
| Elite Orthopedics, LLC | 6 | $706 |
| Arthrex | 13 | $475 |
| Smith+Nephew | 5 | $359 |
| Acumed LLC | 1 | $176 |
| International Life Sciences | 1 | $170 |
| Kerecis Limited | 1 | $170 |
| Averitas Pharma Inc. | 5 | $165 |
| Nevro Corp. | 2 | $160 |
| Biowound Solutions, Inc. | 1 | $157 |
| AbbVie | 2 | $140 |
| Solventum Corporation | 3 | $137 |
| Amgen | 1 | $111 |
| Aroa Biosurgery Incorporated | 3 | $42 |
| DJO, LLC | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Treace Medical Concepts, Inc. | 1 | $19 |
| Access Pro Medical, LLC | 1 | $15 |
| Medwest Associates | 1 | $15 |
| Lifenet Health | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMNIOEXCEL$946
- INTEGRA$788
- Kerecis SurgiClose$678
- AUGMENT INJECTABLE$570
- PROstep$510
- GRAFIX PL$266
- INTEGRA DERMAL REGENERATION TEMPLATE$263
- PRIMATRIX$263
- MICROMATRIX$245
- OMNIGRAFT$232
- ACUMED$176
- FLEXBAND$170
- Kerecis GraftGuide$170
- bio-ConneKt$157
- N/A$147
- PURAPLY WOUND MATRIX$146
- Viaflow$146
- STRAVIX PL$142
- INFINITY$132
- Qutenza$125
How this compares
$7,355 in reported general payments places this provider in the 60th percentile of 163 foot & ankle surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 131 | $3,273 |
| Ammonium Lactate | 95 | $1,928 |
| Gentamicin Sulfate | 34 | $1,576 |
| Ciclopirox | 21 | $1,426 |
| Diclofenac Sodium | 44 | $1,255 |
| Nystatin | 21 | $569 |
| NystopNystatin | 11 | $347 |
| Terbinafine Hcl | 13 | $269 |
| Gabapentin | 43 | $191 |
| Doxycycline Hyclate | 23 | $160 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Saint Louis
- Jeremy McCormickSaint Louis$1.5M
- Jeffrey JohnsonSaint Louis$944K
- Raymond AbdoSaint Louis$251K
- Vincent SollecitoSaint Louis$221K
- John HoltzmanSaint Louis$129K
- Jesse WolfeSaint Louis$89K
- Seth AndersonSaint Louis$45K
- Kelly HynesSaint Louis$34K
- Lindsay BarthSaint Louis$30K
- Andrew ThomeSaint Louis$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.